Neurotech Competitors and Similar CompaniesClear all
Aptinyx's competitors and similar companies include Rubius Therapeutics.
 Aptinyx Aptinyx is a clinical-stage biopharmaceutical company focused on the discovery and development of transformative therapies for challenging neurologic disorders. | ||
Founding Date | Founding Date 2015 | Founding Date 2013 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Evanston, US HQ Evanston, US | Locations Cambridge, US HQ Smithfield, US |
Employees | Employees 635% increase | Employees 17423% increase |
Valuation ($) | Valuation ($) 4.1 m | Valuation ($) 7.5 m |
Financial | ||
Net income | Net income ($64.8m) (FY, 2022) | Net income ($179.7m) (FY, 2022) |
Funding | ||
Total funding raised | Total funding raised $ 135m | Total funding raised $ 245m |
For sources of this data, please see the company profile
View Company Profiles
Rubius Therapeutics
HQ
Cambridge, US
Employees
174↑ 23% increase
Rubius is developing a new class of drugs, Red-Cell Therapeutics™.
View company